Jiehui Deng

6.2k total citations · 1 hit paper
34 papers, 2.9k citations indexed

About

Jiehui Deng is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jiehui Deng has authored 34 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Jiehui Deng's work include Cytokine Signaling Pathways and Interactions (12 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Jiehui Deng is often cited by papers focused on Cytokine Signaling Pathways and Interactions (12 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Jiehui Deng collaborates with scholars based in United States, China and Hong Kong. Jiehui Deng's co-authors include Hua Yu, Heehyoung Lee, Maciej Kujawski, Andreas Herrmann, Richard Jove, Stephen J. Forman, Drew M. Pardoll, Guilian Niu, Marcin Kortylewski and Zhiwei Li and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Jiehui Deng

32 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors

2009 558 citations Heehyoung Lee, Andreas Herrmann et al. Cancer Cell profile →

Peers

Countries citing papers authored by Jiehui Deng

Since Specialization

Citations

This map shows the geographic impact of Jiehui Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiehui Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiehui Deng more than expected).

Fields of papers citing papers by Jiehui Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiehui Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiehui Deng. The network helps show where Jiehui Deng may publish in the future.

Co-authorship network of co-authors of Jiehui Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiehui Deng. A scholar is included among the top collaborators of Jiehui Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiehui Deng. Jiehui Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945 2025 ·npj Precision Oncology ·(unknown), Yuan Hao, Michela Ranieri, Tigran M. Abramyan, (unknown), (unknown), (unknown), (unknown), (unknown), Jiehui Deng, (unknown), Garegin A. Papoian, Kwok‐Kin Wong, Elaine Shum, John T. Poirier	1
2	Value of spectral CT parameters in predicting the efficacy of neoadjuvant chemotherapy for gastric cancer 2023 ·Clinical Radiology ·Jiehui Deng, Wengang Zhang, Mingyuan Xu, Xin Liu, Tianhui Ren, Shuhui Li, Qingfeng Sun, Chunyan Xue, Junlin Zhou	6
3	A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer 2023 ·Molecular Cancer Therapeutics ·(unknown), Jeffrey A. Schneider, Susan Ha, Rachel Ruoff, (unknown), Joseph Puccini, Michela Ranieri, Rüveyda Ayasun, Jiehui Deng, (unknown), Dafna Bar‐Sagi, Kwok‐Kin Wong, Amina Zoubeidi, Frank Claessens, David R. Wise, Susan K. Logan, Kent Kirshenbaum, Michael J. Garabedian	2
4	Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non–small cell lung cancer 2022 ·Science Advances ·Qingyuan Huang, Fei Li, Hai Hu, Zhaoyuan Fang, Zhendong Gao, (unknown), Wai‐Lung Ng, Alireza Khodadadi‐Jamayran, Ting Chen, Jiehui Deng, Hua Zhang, Christina Almonte, Kristen Labbe, Han Han, Ke Geng, (unknown), Gordon J. Freeman, Yuan Li, Haiquan Chen, Kwok‐Kin Wong	24
5	DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome 2022 ·Clinical Cancer Research ·(unknown), Varshini Vasudevaraja, Kristen Labbe, (unknown), Jonathan Serrano, (unknown), Michael DeLorenzo, Hua Zhang, Jiehui Deng, Soumyadip Sahu, Christina Almonte, André L. Moreira, Aristotelis Tsirigos, Thales Papagiannakopoulos, Harvey I. Pass, Matija Snuderl, Kwok‐Kin Wong	18
6	The KRASG12C Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy 2021 ·Molecular Cancer Therapeutics ·David M. Briere, Shuai Li, Andrew Calinisan, Niranjan Sudhakar, Ruth Aranda, Lauren Hargis, David H. Peng, Jiehui Deng, Lars D. Engstrom, Jill Hallin, Sole Gatto, Julio Fernandez-Banet, Adam Pavlı́c̀ek, Kwok‐Kin Wong, James G. Christensen, Peter Olson	109
7	Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment 2020 ·Breast Cancer Research and Treatment ·Jiehui Deng, Aatish Thennavan, (unknown), Ece Bagdatlioglu, (unknown), Adriana Heguy, Christian Marier, Peter Meyn, Yutong Zhang, Kristen Labbe, Christina Almonte, Michelle Krogsgaard, Charles M. Perou, Kwok‐Kin Wong, Sylvia Adams	14
8	Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms 2018 ·Cancer Discovery ·Annan Yang, Grit S. Herter-Sprie, Haikuo Zhang, Elaine Y. Lin, Douglas E. Biancur, Xiaoxu Wang, Jiehui Deng, Josephine Hai, Shenghong Yang, Kwok‐Kin Wong, Alec C. Kimmelman	240
9	STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis 2015 ·Cancer Immunology Research ·Chanyu Yue, Shudan Shen, Jiehui Deng, Saul J. Priceman, Wenzhao Li, Austin Huang, Hua Yu	74
10	S1PR1 Is Crucial for Accumulation of Regulatory T Cells in Tumors via STAT3 2014 ·Cell Reports ·Saul J. Priceman, Shudan Shen, Lin Wang, Jiehui Deng, Chanyu Yue, Maciej Kujawski, Hua Yu	78
11	Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma 2013 ·PLoS ONE ·Shasha Li, Saul J. Priceman, Xin Hong, Wang Zhang, Jiehui Deng, Yong Liu, (unknown), (unknown), Mingjie Chen, Wei Hu, Xiaomin Deng, Jian Zhang, Hua Yu, Guangyuan He	98
12	G-protein-coupled Receptor Agonist BV8/Prokineticin-2 and STAT3 Protein Form a Feed-forward Loop in Both Normal and Malignant Myeloid Cells 2013 ·Journal of Biological Chemistry ·Xin Hong, Rongze Lu, Heehyoung Lee, Wang Zhang, Chunyan Zhang, Jiehui Deng, Yong Liu, Shudan Shen, Kay‐Uwe Wagner, Stephen J. Forman, Richard Jove, Hua Yu	48
13	Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer 2013 ·PLoS ONE ·Chunmei Yang, Heehyoung Lee, Veronica Jové, Jiehui Deng, Wang Zhang, Xueli Liu, Stephen J. Forman, Thanh H. Dellinger, Mark T. Wakabayashi, Hua Yu, Sumanta K. Pal	51
14	The behavior oriented detection of malicious code overview 2012 ·Jiehui Deng, Dan Liu, (unknown), (unknown)	1
15	S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites 2012 ·Cancer Cell ·Jiehui Deng, (unknown), Heehyoung Lee, Andreas Herrmann, Wang Zhang, Chunyan Zhang, Shudan Shen, Saul J. Priceman, Maciej Kujawski, Sumanta K. Pal, Andrew Raubitschek, Dave S.�B. Hoon, Stephen J. Forman, Robert A. Figlin, Jie Liu, Richard Jove, Hua Yu	201
16	Targeting STAT3 in Adoptively Transferred T Cells Promotes Their In Vivo Expansion and Antitumor Effects 2010 ·Cancer Research ·Maciej Kujawski, Chunyan Zhang, Andreas Herrmann, Karen L. Reckamp, Anna Scuto, Michael C. Jensen, Jiehui Deng, Stephen J. Forman, Robert A. Figlin, Hua Yu	99
17	Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells 2010 ·Cancer Research ·Andreas Herrmann, Marcin Kortylewski, Maciej Kujawski, Chunyan Zhang, Karen L. Reckamp, Brian Armstrong, Lin Wang, Claudia Kowolik, Jiehui Deng, Robert A. Figlin, Hua Yu	110
18	Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors breakdown → 2009 ·Cancer Cell ·Heehyoung Lee, Andreas Herrmann, Jiehui Deng, Maciej Kujawski, Guilian Niu, Zhiwei Li, (unknown), Richard Jove, Drew M. Pardoll, Hua Yu	558
19	In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses 2009 ·Nature Biotechnology ·Marcin Kortylewski, Piotr Swiderski, Andreas Herrmann, Lin Wang, Claudia Kowolik, Maciej Kujawski, Heehyoung Lee, Anna Scuto, Yong Liu, Chunmei Yang, Jiehui Deng, Harris S. Soifer, Andrew Raubitschek, Stephen J. Forman, John J. Rossi, Drew M. Pardoll, Richard Jove, Hua Yu	302
20	Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1α RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells 2008 ·Molecular Cancer Research ·Guilian Niu, (unknown), Jiehui Deng, Yihong Ma, Heehyoung Lee, Marcin Kortylewski, Maciej Kujawski, H. David Kay, W. Douglas Cress, Richard Jove, Hua Yu	151

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact